Skip to content. | Skip to navigation

Garvan Institute

Sections
 

Professor Don Chisholm AO

 

Senior Principal Research Fellow; Group Leader, Diabetes and Obesity Clinical Studies, Diabetes and Obesity Research Program, Garvan Institute of Medical Research; Professor of Medicine, The University of New South Wales; Staff Endocrinologist, St Vincent's Hospital, Sydney

Email: d.chisholm 'at' garvan.org.au
Research Group: Chisholm

 
 

Education

1973 FRACP
1967 MRACP
1964 MB, BS (Honours) - Robin May Memorial Prize
1957-1963 Faculty of Medicine, University of Sydney

Awards and Honours

2002 Kellion Award, Australian Diabetes Society
1999 Officer, General Division of the Order of Australia
1998 The College Medal; Awarded for outstanding service to the College by the Royal Australasian College of Physicians
1995 Sir Kempson Maddox Award; Diabetes Australia (NSW)

Publications

Greenfield JR, Samaras K, Chisholm DJ. Insulin resistance, intra-abdominal fat, cardiovascular risk factors and androgens in healthy young women with Type 1 diabetes mellitus. J Clin Endocrinol Metab 2002; 87:1036-1040.

Ellis BA, Poynten A, Lowy A, Furler SM, Chisholm DJ, Kraegen EW, Cooney GJ. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol (Endocrinol Metab) 2000; 279:E554-E560.

Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction and natural course of HIV-1 protease-inhibitor-associated lipodustrophy, hyperlipidaemia and diabetes mellitus: a cohort study. The Lancet 1999; 353:2093-2099.

Markovic TP, Campbell LV, Balasubramanian S, Jenkins AB, Fleury AC, Simons L, Chisholm DJ. Beneficial effect on average lipid levels from energy restriction and fat loss in obese individuals with or without Type 2 diabetes. Diabetes Care 1998; 21:695-700.

Carr A, Samaras K, Chisholm DJ, Cooper DA. Pathogenesis of HIV protease inhibitor-associated syndrome of peripheral lipodystrophy, hyperlipiaemia and insulin resistance. The Lancet 1998; 351:1881-1883.

Markovic TP, Jenkins AB, Campbell LV, Furler SM, Kraegen EW, Chisholm DJ. The determinants of glycaemic responses to diet restriction and weight loss in obesity and NIDDM. Diabetes Care 1998; 21:687-694.

Oakes ND, Bell KS, Furler SM, Camilleri S, Saha AK, Ruderman NB, Chisholm DJ, Kraegen EW. Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise. Diabetes 1997; 46:2022-2028.

Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996; 45:633-638.

Carey DGP, Campbell LV, Chisholm DJ, Nguyen TV, Kelly P. Genetic influences on central abdominal fat: a twin study. Int J Obesity 1996; 20:722-726.

Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. New Engl J Med 1993; 328:238-244.

 

Search for all publications by DJ Chisholm

 
 
 

Areas of Interest

Diabetes mellitus, carbohydrate metabolism, type 2 diabetes, insulin resistance, fat metabolism, muscle triglycerides, obesity
 

News

 

Shot in the arm for Type 1 diabetes prevention in Australia

MEDIA RELEASE: 14 Jul 2010
The Federal Government has committed $6.5 million over the next five years for the Diabetes Vaccine Development Centre (DVDC), based at Garvan, to continue its work. DVDC is searching for ways to prevent the development of Type 1 diabetes, including vaccination and immunotherapy, and to preserve insulin-producing cells from the early stages of disease.
 
 

Surprising findings about Hepatitis C and insulin resistance

MEDIA RELEASE: 09 Mar 2010
Researchers at Garvan have now confirmed the link between Hepatitis C and Type 2 diabetes - people with the virus being 3 to 4 times more likely to develop diabetes, owing to high levels of insulin resistance in muscle. There is practically no insulin resistance in the liver, however, a surprising finding given that Hepatitis C is a liver disease.
 
 

Research Fellowship announcement to support link between weight loss and the reversal of Type 2 diabetes

MEDIA RELEASE: 27 Oct 2009
Associate Professor Katherine Samaras is the new recipient of the GlaxoSmithKline (GSK) Don Chisholm Diabetes Research Fellowship. The Fellowship is dedicated to funding vital research into the causes, processes and treatments for Type 2 diabetes, one of Australia’s most common and serious diseases – and is named in honour of Professor Don Chisholm, who is recognised as a leader in clinical diabetes research.
 
 

Personal tools